81 related articles for article (PubMed ID: 16298686)
1. GDNF modulates HO-1 expression in substantia nigra postnatal cell cultures.
Saavedra A; Baltazar G; Carvalho CM; Duarte EP
Free Radic Biol Med; 2005 Dec; 39(12):1611-9. PubMed ID: 16298686
[TBL] [Abstract][Full Text] [Related]
2. Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk.
Saavedra A; Baltazar G; Santos P; Carvalho CM; Duarte EP
Neurobiol Dis; 2006 Sep; 23(3):533-42. PubMed ID: 16766196
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of heme oxygenase-1 action involved in the enhancement of neurotrophic factor expression.
Hung SY; Liou HC; Fu WM
Neuropharmacology; 2010 Feb; 58(2):321-9. PubMed ID: 19925812
[TBL] [Abstract][Full Text] [Related]
4. H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways.
Fonseca CP; Gama S; Saavedra A; Baltazar G
Biochim Biophys Acta; 2014 Jul; 1842(7):927-34. PubMed ID: 24632468
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity.
Hung SY; Liou HC; Kang KH; Wu RM; Wen CC; Fu WM
Mol Pharmacol; 2008 Dec; 74(6):1564-75. PubMed ID: 18799798
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta mediates GDNF up-regulation upon dopaminergic injury in ventral midbrain cell cultures.
Saavedra A; Baltazar G; Duarte EP
Neurobiol Dis; 2007 Jan; 25(1):92-104. PubMed ID: 17027275
[TBL] [Abstract][Full Text] [Related]
7. Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures.
Jaumotte JD; Zigmond MJ
J Neurosci Res; 2014 Nov; 92(11):1425-33. PubMed ID: 24916473
[TBL] [Abstract][Full Text] [Related]
8. Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway.
Wang HJ; Cao JP; Yu JK; Zhang LC; Jiang ZJ; Gao DS
Eur J Pharmacol; 2008 Oct; 595(1-3):7-12. PubMed ID: 18703048
[TBL] [Abstract][Full Text] [Related]
9. The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease.
Tanriover G; Seval-Celik Y; Ozsoy O; Akkoyunlu G; Savcioglu F; Hacioglu G; Demir N; Agar A
Folia Histochem Cytobiol; 2010 Sep; 48(3):434-41. PubMed ID: 21071351
[TBL] [Abstract][Full Text] [Related]
10. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke.
Kuric E; Wieloch T; Ruscher K
Exp Neurol; 2013 Sep; 247():202-8. PubMed ID: 23664961
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
13. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
14. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease.
Schipper HM; Liberman A; Stopa EG
Exp Neurol; 1998 Mar; 150(1):60-8. PubMed ID: 9514830
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of glial cell line-derived neurotrophic factor on A9 and A10 dopamine neuron survival in vitro.
Borgal L; Hong M; Sadi D; Mendez I
Neuroscience; 2007 Jul; 147(3):712-9. PubMed ID: 17583436
[TBL] [Abstract][Full Text] [Related]
16. Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons.
Piltonen M; Bespalov MM; Ervasti D; Matilainen T; Sidorova YA; Rauvala H; Saarma M; Männistö PT
Exp Neurol; 2009 Oct; 219(2):499-506. PubMed ID: 19615368
[TBL] [Abstract][Full Text] [Related]
17. GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action.
Schober A; Peterziel H; von Bartheld CS; Simon H; Krieglstein K; Unsicker K
Neurobiol Dis; 2007 Feb; 25(2):378-91. PubMed ID: 17141511
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
19. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
Ding YM; Jaumotte JD; Signore AP; Zigmond MJ
J Neurochem; 2004 May; 89(3):776-87. PubMed ID: 15086533
[TBL] [Abstract][Full Text] [Related]
20. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
